Retort Vincent

Retort Vincent sold 3,183 shares of Lumentum (LITE) at $953.95 under pre-arranged 10b5-1 plan; stock now $890.09.

Retort Vincent executed a scheduled sale of 3,183 shares at $953.95 as part of a pre-arranged 10b5-1 trading plan adopted on 2025-11-13, reducing holdings from 92,746 to 89,563 shares. The current stock price of $890.09 is 18.0% below the 52-week high, and the transaction occurred at a price above current market levels, indicating a point-in-time market valuation rather than a discretionary decision signal. His prior open-market sales across all tickers show an average 90-day return of +65.5%, and his five prior sales specifically at Lumentum ranged from 30-day returns of +38.8% to +43.3% and 90-day returns of +59.1% to +64.3%, establishing a track record pattern at this ticker. Since this sale is part of a scheduled trading plan, the timing is predetermined rather than responsive to current market conditions.

Retort Vincent sold 3,441 shares at $545.78 blended average for $1.9M on 2026-02-17 at Lumentum Holdings.

Retort Vincent executed 16 separate sales totaling 3,441 shares for $1,878,025.39 on 2026-02-17, reducing his position from 99,416 shares to 95,975 shares (-3.5% vs pre-transaction holdings). The blended average transaction price of $545.78 sits within the 52-week range ($49.56–$600.42) and is approximately 8.2% below the current price of $594.26, suggesting the insider sold into strength relative to today's market. The sale quantity and dollar magnitude are material—worth noting given the company's $42.4B market cap and strong recent performance (30-day change: +83.3%, 90-day change: +154.8%). Notably, Retort Vincent executed five separate sales at Lumentum on 2026-02-12 (just five days prior), now followed by this larger 16-transaction sale block, signaling sustained liquidation activity at this ticker rather than an isolated transaction. No timing pattern is yet measurable for the 2026-02-12 trades due to insufficient elapsed time.

Vincent Retort sold 45,026 shares at LITE for $26.6M (blended avg $591.32), reducing stake by 30.5%

Retort Vincent executed 23 separate sales totaling 45,026 shares for $26,624,902.78 on 2026-02-12 at prices ranging from $576.35 to $601.82, with a blended average price of $591.32. This represents a 30.5% reduction in holdings from 147,481 to 102,455 shares post-transaction. The transaction occurred near the 52-week high ($583.46), with current price at $562.74 (-3.6% from peak), and follows strong near-term appreciation (30-day change +69.7%, 90-day change +142.4%). At this specific ticker, Retort's prior 4 trades show a 75.0% well-timed rate at the 90-day mark, with the most recent sale on 2025-07-29 posting a 90d return of +76.2%—a poorly-timed outcome where the stock continued rising after sale. The current filing's execution near all-time highs aligns with the general pattern of Retort's cross-ticker track record (90d well-timed rate 75.00%), though context on whether this sale is scheduled (10b5-1) versus discretionary is absent from the filing.

LITE President Retort Vincent sold 22,719 shares at $110.00 (within 0.0% of 52-week high); prior same-ticker sales all generated negative 90-day returns.

Retort Vincent, President of Industrial Tech. at Lumentum, sold 22,719 shares at $110.00 on 2025-07-29, reducing his holdings by -15.7% and realizing $2,499,090.00 in proceeds. The sale occurred near the 52-week high ($110.08 current price; transaction at $110.00, +0.0% from peak), and the stock has gained +20.3% over 30 days and +75.1% over 90 days—a sharp recovery. However, his prior transaction history at LITE reveals a consistent pattern: all 3 prior same-ticker sales (on 2024-11-25) produced negative 90-day returns ranging from -17.6% to -19.2%, with a 100% well-timed rate, suggesting the insider has historically sold ahead of subsequent declines at this ticker. Against this backdrop, the current sale coincides with Lumentum's fundamental weakness: the company reported an annual revenue decline of -23.1%, a net loss of $-44,100,000.00 in the most recent quarter, and unprofitability over the latest full fiscal year. The timing of a large sell by a seasoned insider at a near-peak price, paired with demonstrated historical prescience on LITE sales and deteriorating fundamentals, warrants attention to forward returns.

President Vincent Retort sells 41,710 shares ($3.7M) at $89.52 average; stock down 23.1% YoY, unprofitable

Retort sold 41,710 shares across 3 separate transactions on 2024-11-25 for $3,733,828.44, reducing his holdings by 22.0% from 189,225 to 147,515 shares. The sales occurred at prices ranging from $89.02 to $90.77, slightly above the current price of $86.98 but well below the 52-week high of $89.09. The timing is noteworthy given Lumentum's underlying operational stress: the company posted a net loss of $82,400,000.00 in its most recent quarter and annual revenue contracted by 23.1% year-over-year, signaling material business headwinds. The divestiture size (22% of holdings) combined with deteriorating fundamentals—particularly the ongoing unprofitability—warrants investor attention to whether this signals management reassessment of near-term recovery prospects.